In Search Of Antivirals For The Next Pandemic, A New Fund To De-Risk R&D

First Target Is Worrying Nipah Virus Family

Paxlovid
Pfizer's Paxlovid is now being rolled out two years into the pandemic - the world can be better prepared next time, but early antiviral drug discovery needs to be properly funded. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip